XML 28 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities      
Net income $ 1,339 $ 420 $ 665
Adjustments to reconcile net income to net cash provided by operating activities      
Depreciation and amortization 601 378 246
Stock-based compensation expense 23 14 10
Gains realized on previously held shares of Axiall common stock and from sales of securities 0 (54) (4)
Gain on acquisition, net of loss on the fair value remeasurement of preexisting equity interest 0 0 (21)
Loss from disposition of property, plant and equipment 22 9 11
Deferred income taxes (534) 101 40
Other losses, net (3) 5 6
Changes in operating assets and liabilities, net of effect of business acquisitions      
Accounts receivable (40) 50 63
Inventories (32) (62) 99
Prepaid expenses and other current assets 26 11 (4)
Accounts payable 86 12 (22)
Accrued liabilities 115 48 (8)
Other, net (65) (98) (2)
Net cash provided by operating activities 1,538 834 1,079
Cash flows from investing activities      
Acquisition of business, net of cash acquired (13) (2,438) 16
Additions to property, plant and equipment (577) (629) (491)
Additions to cost method investment (66) (17) 0
Proceeds from disposition of equity method investment 0 0 28
Proceeds from sales and maturities of securities 0 663 49
Purchase of securities 0 (138) (605)
Other 4 (4) (3)
Net cash used for investing activities (652) (2,563) (1,006)
Cash flows from financing activities      
Debt issuance costs (6) (36) 0
Dividends paid (103) (97) (92)
Distributions to noncontrolling interests (28) (17) (15)
Proceeds from debt issuance and drawdown of revolver 233 608 53
Net proceeds from issuance of Westlake Chemical Partners LP common units 111 0 0
Proceeds from senior notes issuance 745 1,429 0
Repayment of term loan (150) 0 0
Restricted cash associated with term loan 154 (154) 0
Repayment of revolver (550) (125) 0
Repayment of notes payable (257) (13) (74)
Repurchase of common stock for treasury 0 (67) (163)
Other 11 5 4
Net cash provided by (used for) financing activities 160 1,533 (287)
Effect of exchange rate changes on cash and cash equivalents 26 (8) (4)
Net increase (decrease) in cash and cash equivalents 1,072 (204) (218)
Cash and cash equivalents at beginning of the year 459 663 881
Cash and cash equivalents at end of the year $ 1,531 $ 459 $ 663